Massive cisplatin overdose by accidental substitution for carboplatin. Toxicity and management

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Cancer

• Publication date

  1993-12-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(19931215)72:12<3707::AID-CNCR2820721224>3.0.CO;2-UPMID 8252487
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemical reactivity of cisplatin bound to human plasma proteins

  2004cited by this paper
• Inefficiency of early prophylactic hemodialysis in cis-platinum overdose

  2004cited by this paper
• Purification and characterization of a human protein that binds to damaged DNA.

  1993cited by this paper
• Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer.

  1992cited by this paper
• Megakaryocyte potentiating activity of IL‐1, IL‐6 and GM‐CSF as evaluated by their action on in vitro human megakaryocytic colonies

  1991cited by this paper
• Chemoprotectants for cancer chemotherapy.

  1991cited by this paper
• Cisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA.

  1990cited by this paper
• Modification of cisplatin toxicity with diethyldithiocarbamate.

  1990cited by this paper
• A constitutive damage-specific DNA-binding protein is synthesized at higher levels in UV-irradiated primate cells

  1990cited by this paper
• The Metabolic basis of inherited disease

  1989cited by this paper
• Dithiocarbamate-induced biliary platinum excretion and the control of cis-platinum nephrotoxicity.

  1989cited by this paper
• Interaction between cisplatin and mesna in mice

  1989cited by this paper
• Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.

  1989cited by this paper
• Inadvertent administration of 480 mg/m2 of cisplatin.

  1989cited by this paper
• Evidence that xeroderma pigmentosum cells from complementation group E are deficient in a homolog of yeast photolyase

  1989cited by this paper
• Overview of carboplatin: replacing, complementing, and extending the therapeutic horizons of cisplatin.

  1989cited by this paper
• Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA.

  1988cited by this paper
• DNA cross-linked by cisplatin: a new probe for the DNA repair defect in xeroderma pigmentosum.

  1987cited by this paper
• Quantitative analysis of cellular glutathione by flow cytometry utilizing monochlorobimane: some applications to radiation and drug resistance in vitro and in vivo.

  1986cited by this paper
• Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA.

  1985cited by this paper
• Retinal toxicity after high-dose cisplatin therapy.

  1985cited by this paper
• Acute Deafness: A Complication of High-Dose Cisplatin

  1985cited by this paper
• Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin.

  1984cited by this paper
• Effect of mannitol and plasma on the cytotoxicity of cisplatin.

  1983cited by this paper
• Intraperitoneal cisplatin with systemic thiosulfate protection.

  1982cited by this paper
• Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamide.

  1980cited by this paper
• Thiourea reverses cross-links and restores biological activity in DNA treated with dichlorodiaminoplatinum (II).

  1979cited by this paper
• Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry.

  1977cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• The zygosity of twins: further evidence on the agreement between diagnosis by blood groups and written questionnaires

  1976cited by this paper
• Diaminodichloroplatinum: A phase I study showing responses in testicular and other tumors

  1974cited by this paper
• Preliminary clinical experience with cis‐diamminedichloroplatinum (II) (NSC 119875, CACP)

  1972cited by this paper
• MONOZYGOTIC AND DIZYGOTIC TWIN DIAGNOSIS

  1955cited by this paper

• Rational design of cisplatin and carboplatin complexes for enhanced anticancer efficacy based on DFT QTAIM and docking analyses

  2026cites this paper
• MAPK signaling reprogramming via integrative TCM-Western medicine strategy: mechanistic interactions between bioactive herbal components and chemotherapy in ovarian cancer therapy — a comprehensive review

  2025cites this paper
• Effect of plasmapheresis on drug pharmacokinetics in children: a structured review of the current literature

  2024cites this paper
• Thermoresponsive carboplatin-releasing prodrugs.

  2024cites this paper
• Therapeutic Plasma Exchange: For Cancer Patients

  2022cites this paper
• Increasing pharmacy productivity and reducing medication turnaround times in an Italian comprehensive cancer center by implementing robotic chemotherapy drugs compounding

  2021cites this paper
• Extracorporeal Therapy for Drug Overdose and Poisoning

  2021cites this paper
• Drug Dosing in Patients Undergoing Therapeutic Plasma Exchange

  2020cites this paper
• Automated detection of wrong-drug prescribing errors

  2019cites this paper
• A structure-based mechanism of cisplatin resistance mediated by glutathione transferase P1-1

  2019cites this paper
• Quantitative and qualitative control of antineoplastic preparations: Gravimetry versus HPLC

  2019cites this paper
• Plasmapheresis in Acute Intoxication and Poisoning

  2019cites this paper
• Therapeutic Plasma Exchange

  2019cites this paper
• Approaches to the Search of Platinum Anticancer Agents: Derivatizing Current Drugs and Incorporating HDAC Inhibition

  2019cites this paper
• Cisplatin: The first metal based anticancer drug.

  2019cites this paper
• Title Chemotherapy for primary mediastinal yolk sac tumor in apatient undergoing chronic hemodialysis : a case report

  2019cites this paper
• CHARACTERIZATION OF MOLECULAR AND GENETIC DETERMINANTS OF POLY (ADP-RIBOSE) POLYMERASE INHIBITOR SENSITIVITY IN OVARIAN CANCER

  2018cites this paper
• Fatal overdosage with cisplatin by accidental substitution for carboplatin : a case report

  2018cites this paper
• Therapeutic Plasma Exchange and Its Impact on Drug Levels: An ACLPS Critical Review

  2017cites this paper
• Urinary TIMP 2 ⋅ IGFBP 7 for the prediction of platinum-induced acute renal injury

  2017cites this paper
• Urinary TIMP2⋅IGFBP7 for the prediction of platinum-induced acute renal injury

  2017cites this paper
• Chemotherapy for primary mediastinal yolk sac tumor in a patient undergoing chronic hemodialysis: a case report

  2017cites this paper
• Effect of ethanolic leaves extract of phyllantus amarus on cisplatin induced nephrotoxicity in albino rats

  2016cites this paper
• Chemotherapy medication errors nursing education and review of literatures.

  2016cites this paper
• Nephroprotective Effect of Bauhinia tomentosa Linn against Cisplatin-Induced Renal Damage.

  2016cites this paper
• Risk Management of in-hospital Administration of Anticancer Drugs: Impact of Raccomandazione 14 from the Italian Ministry of Health

  2016cites this paper
• A comparative study: effect of platinum compounds viz. cisplatin, carboplatin and oxaliplatin on blood parameters

  2015cites this paper
• Fluorometric imaging methods for palladium and platinum and the use of palladium for imaging biomolecules.

  2015cites this paper
• EPICC study: evaluation of pharmaceutical intervention in cancer care

  2015cites this paper
• Available Extracorporeal Treatments for Poisoning: Overview and Limitations

  2014cites this paper
• Extracorporeal Treatments for Poisoning : Overview and Limitations

  2014cites this paper
• A Stepwise Approach for the Management of Poisoning with Extracorporeal Treatments

  2014cites this paper
• Pharmacokinetics of Anti-cancer Chemotherapy in Renal Insufficiency and Dialysis

  2014cites this paper
• Ginger Essential Oil Ameliorates Cisplatin-Induced Nephrotoxicity in Mice

  2014cites this paper
• Cell membrane morphology analysis using an infrared sensor system

  2013cites this paper
• Synthetic methods for the preparation of platinum anticancer complexes.

  2013cites this paper
• Impact of electronic chemotherapy order forms on prescribing errors at an urban medical center: results from an interrupted time-series analysis.

  2013cites this paper
• Fatal Cisplatin Overdose in the Treatment of Mediastinal Lymphoma with the ESHAP Regimen – Analysis of the Causes of the Adverse Drug Event

  2013cites this paper
• The Role of Therapeutic Plasma Exchange in Poisonings and Intoxications

  2012cites this paper
• Predictors of prescription errors involving anticancer chemotherapy agents.

  2012cites this paper
• Ototoxic Hearing Loss and Retinoblastoma Patients

  2012cites this paper
• Medications in Patients Treated With Therapeutic Plasma Exchange: Prescription Dosage, Timing, and Drug Overdose

  2012cites this paper
• Biochemical and histologic study of lethal cisplatin nephrotoxicity prevention by mirtazapine

  2012cites this paper
• Optimization of cisplatin doses in a testicular cancer patient with acute renal failure

  2011cites this paper
• Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs

  2011cites this paper
• A label-free sensor system for chemotherapeutic drug screening

  2011cites this paper
• Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?

  2010cites this paper
• Role of N-Acetylcystein in Protection against Cisplatin Nephrotoxicity

  2010cites this paper
• Successful Treatment of Cisplatin Overdose with Plasma Exchange

  2010cites this paper
• Cisplatin Overdose

  2009cites this paper
• Cisplatin preparation error; patient management and morbidity

  2009cites this paper
• Protection against cisplatin-induced nephrotoxicity in mice by Curcuma comosa Roxb. ethanol extract

  2009cites this paper
• Therapeutic Plasma Exchange

  2009cites this paper
• Trace analysis of platinum in blood and urine by ESI-MS-MS

  2007cites this paper
• Drug Removal by Plasmapheresis: An Evidence‐Based Review

  2007cites this paper
• Chapter 16. Preventing Medication Errors in Cancer Chemotherapy

  2007cites this paper
• Plasmapheresis reverses all side-effects of a cisplatin overdose – a case report and treatment recommendation

  2006cites this paper
• Platinum levels in various tissues of a patient who died 181 days after cisplatin overdosing determined by electrospray ionization mass spectrometry

  2006cites this paper
• Modulation of telomerase activity and human telomerase reverse transcriptase expression by caspases and bcl-2 family proteins in Cisplatin-induced cell death.

  2006cites this paper
• Determination of platinum derived from cisplatin in human tissues using electrospray ionization mass spectrometry.

  2006cites this paper
• Fatal overdosage with cisplatin.

  2004cites this paper
• Enhanced chemosensitivity of bladder cancer cells to cisplatin by suppression of clusterin in vitro.

  2004cites this paper
• Cisplatin nephrotoxicity: molecular mechanisms.

  2003cites this paper
• Typical Medication Errors in Oncology: Analysis and Prevention Strategies

  2003cites this paper
• Therapeutic plasma exchange for multidrug intoxication: A case report

  2003cites this paper
• KARBOPLATİNE BAĞLI ORGAN TOKSİSİTELFRİNDE PENTOKSİFİLİN, C VİTAMİNİ VE E VİTAMİNİNİN ETKİSİ* THE EFFECT OF PENTOXIFYLLINE, VİTAMİN C AND VİTAMİN E ON THE ORGAN TOXICITY OF CARBOPLATIN

  2003cites this paper
• Chemotherapy errors in oncology

  2002cites this paper
• Fighting medication errors: Results of a study and reflections on causes and ways for prevention

  2002cites this paper
• MEDICATION E RRORS: CAUSES, P REVENTION A ND REDUCTION

  2002cites this paper
• [Dysarthria during irinotecan administration].

  2002cites this paper
• Topical topic: accidental cisplatin overdose in a child: reversal of acute renal failure with sodium thiosulfate.

  2002cites this paper
• Successful treatment of cisplatin overdose with plasma exchange.

  2002cites this paper
• MEDICATION ERRORS: CAUSES, PREVENTION AND REDUCTION

  2002cites this paper
• Editorial: chemotherapy errors in oncology.

  2002cites this paper
• Sodium phenylbutyrate induces apoptosis in human retinoblastoma Y79 cells: the effect of combined treatment with the topoisomerase I-inhibitor topotecan.

  2001cites this paper
• Desarrollo de un método observacional prospectivo de estudio de Errores de Medicación para su aplicación en hospitales

  2001cites this paper
• Therapeutic apheresis in renal and metabolic diseases

  2000cites this paper
• Accidental Iatrogenic Intoxications by Cytotoxic Drugs

  1999cites this paper
• Conflicting Roles of Mismatch and Nucleotide Excision Repair in Cellular Susceptibility to Anticancer Drugs

  1998cites this paper
• Cisplatin resistance in cyclic AMP-dependent protein kinase mutants.

  1998cites this paper
• The apoptotic effects of cisplatin and carboplatin in retinoblastoma Y79 cells.

  1998cites this paper
• Cisplatin pharmacokinetics in children with cancer.

  1997cites this paper
• A Review of the Effects of Plasmapheresis on Drug Clearance

  1997cites this paper
• Cisplatin-induced renal toxicity: possible reversal by N-acetylcysteine treatment.

  1997cites this paper
• Original Paper Cisplatin Pharmacokinetics in Children with Cancer

  1997cites this paper
• Characterization of a cAMP‐dependent protein kinase mutant resistant to cisplatin

  1997cites this paper
• Fundamental study of thermochemotherapy combined withcis-diammine-1, 1-cyclobutane dicarboxylate platinum (II) and hyperthermia

  1996cites this paper
• 16 – Anticancer drugs and immunomodulators

  1996cites this paper
• Antitumor effect of carboplatin combined with hyperthermia on Ehrlich-ascites tumor in vivo.

  1996cites this paper
• A Case of Massive Cisplatin Overdose Managed by Plasmapheresis

  1995cites this paper
• Echanges plasmatiques

  1995cites this paper
• Effect of low-dose prophylactic dopamine on high-dose cisplatin-induced electrolyte wasting, ototoxicity, and epidermal growth factor excretion: a randomized, placebo-controlled, double-blind trial.

  1995cites this paper
• Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair.

  1994cites this paper